Meet the EIP team heading to INTA 2026 in London

INTA's Annual Meeting is coming to London. From 2–6 May 2026, the ExCeL will host more than 10,000 trade mark and IP professionals from over 100 jurisdictions — five days of sessions, side events, and the kind of corridor conversations that turn into lasting working relationships.

For us, having INTA on home turf is a rare thing. It means shorter travel, longer conversations, and more time to show you around the city we know best. Whether you're a first-timer weighing up which sessions to prioritise, or a regular working out which receptions are worth the trip across town, we want to help you make the most of it.

For a practical run-down of what to do, where to go, and how to plan your week, have a read of our INTA 2026 Essentials Guide — your companion for the whole event.

In the meantime, here's who you'll find from our team on the ground.

Paula Flutter

Partner | UK and European Patent Attorney | Trade Mark Attorney

Paula is one of our most versatile partners, working across patents, trade marks, and designs. Her technical range is unusually broad — medical devices, automotive engineering, manufacturing, energy, consumer products, and more — and she advises clients across all of these.

She's spent time on secondment inside client businesses, which shapes how she works: commercially grounded, pragmatic, and focused on helping clients actually get where they want to go. She regularly handles opposition and appeal proceedings at the European Patent Office, and has enforced IP rights for clients across sectors.

Paula is also a fluent German speaker, with working knowledge of French and Spanish — useful at a meeting where the delegate list spans 100-plus jurisdictions.

If you'd like to talk trade mark strategy, design protection, or how to get the most out of a European portfolio, Paula would love to connect.

Rob Barker

Partner | UK and European Patent Attorney | Design Attorney | UPC Representative

Rob is a partner in our biopharma team and a qualified UPC Representative, advising clients on patent strategy, design protection, and contentious work at the Unified Patent Court. He's part of the team running our recent Make your (bio)pharma IP investment-ready LinkedIn Live series, exploring how companies can position their IP to support funding, partnerships, and long-term value.

He's particularly good to speak to if you're thinking about how your patent and design strategy supports a wider commercial goal — getting ready for an investment round, navigating due diligence, or planning a launch across Europe under the UPC.

If any of that's on your mind for 2026, Rob is happy to find time during the week.